ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4137
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,391.98
0.09%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Social Capital Suvretta Holdings Corporation III (DNAC)

  7. Social Capital Suvretta Holdings Corporation III (DNAC) Noticias

DNAC

Social Capital Suvretta ... (DNAC)

Social Capital Suvretta Holdings Corporation III
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DNAC
FechaHoraFuenteTítuloSímboloCompañía
16/06/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
26/05/202307:01Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
26/05/202306:33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
11/05/202315:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
21/04/202305:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
17/04/202316:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
04/04/202315:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
29/03/202305:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
28/03/202315:47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
14/02/202311:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
06/01/202315:59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
26/08/202215:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
12/08/202206:16Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
09/08/202205:10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
22/07/202215:40Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
22/07/202205:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
20/07/202215:32Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
12/07/202207:00GlobeNewswire Inc.Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. IIINASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
08/07/202218:36Business WireSocial Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of ShareholdersNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
06/07/202207:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
23/06/202207:00GlobeNewswire Inc.ProKidney Corroborates the Mechanism of Action of REACT™ with Cell Marker Analysis in Patients with Diabetic Chronic Kidney DiseaseNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
15/06/202207:00GlobeNewswire Inc.ProKidney Announces Manufacturing Efficiency Initiatives and Supply Chain Streamlining Expected to Reduce REACT™ Manufacturing CostsNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
10/06/202215:55Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
07/06/202207:00GlobeNewswire Inc.Observed Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 UpdateNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
20/05/202208:00GlobeNewswire Inc.ProKidney to present at upcoming investor conferencesNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
06/05/202215:48Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
03/05/202207:00GlobeNewswire Inc.ProKidney highlights key registrational program elements supporting advancement of REACT®NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
18/04/202208:30GlobeNewswire Inc.ProKidney and Social Capital Suvretta Holdings Corp. III (“SCS”) to Host Analyst and Investor Day on April 28, 2022NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
12/04/202207:00GlobeNewswire Inc.ProKidney confirms Phase 3 program for autologous kidney cell therapy REACT®NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
14/02/202216:14Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
 Showing the most relevant articles for your search:NASDAQ:DNAC

Su Consulta Reciente

NYSE
CVX
Chevron
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
SILVER
SILVER
NYSE
XOM
Exxon Mobil
USI
USTECH100
US Tech 100
CCOM
US500
US 500
NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
CCOM
US30
US 30
FX
USDMXN
US Dollar vs MXN
NYSE
NKE
Nike
PM
XAUUSD
Gold vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados